Live from the NIH registry
Studies recruiting near Fargo right now
Top 25 of 201 recruiting studies, sorted by proximity — each links to its official registry page
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Sanford Roger Maris Cancer Center — Fargo, North Dakota (2.0 mi)
· Sponsor: NRG Oncology
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
Periprosthetic Joint Infections
N/A
Interventional 204 participants sought
Sanford South University Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Elute, Inc.
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Children's Oncology Group
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Atopic Dermatitis (AD), Psoriasis (PsO)
Phase 1
Interventional 48 participants sought
Red River Research Partners — Fargo, North Dakota (2.0 mi)
· Sponsor: LAPIX Therapeutics Inc.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Red River Research Partners — Fargo, North Dakota (2.0 mi)
· Sponsor: Incyte Corporation
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0065) — Fargo, North Dakota (2.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Sanford Health - Fargo — Fargo, North Dakota (2.0 mi)
· Sponsor: Novo Nordisk A/S
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Red River Research Partners - Fargo- Site Number : 8400037 — Fargo, North Dakota (2.0 mi)
· Sponsor: Sanofi
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
B Acute Lymphoblastic Leukemia Associated With Down Syndrome, Down Syndrome
N/A
Observational 330 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Children's Oncology Group
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
Phase 2, Phase 3
Interventional 440 participants sought
Sanford Roger Maris Cancer Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Exelixis
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Sanford Health- Fargo — Fargo, North Dakota (2.0 mi)
· Sponsor: American Society of Clinical Oncology
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: PedAL BCU, LLC
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Cancer, Metastatic, Cancer
N/A
Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Fargo, North Dakota (2.0 mi)
· Sponsor: Massive Bio, Inc.
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: NRG Oncology
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Red River Research Partners — Fargo, North Dakota (2.0 mi)
· Sponsor: Incyte Corporation
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Pyoderma Gangrenosum
Phase 3
Interventional 90 participants sought
Red River Research Partners, LLC — Fargo, North Dakota (2.0 mi)
· Sponsor: LEO Pharma
The Minimalist Trial-2
HPV-Related Oropharynx Squamous Cell Carcinoma
Phase 2
Interventional 142 participants sought
Sanford Roger Maris Cancer Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Washington University School of Medicine
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: National Cancer Institute (NCI)